166 related articles for article (PubMed ID: 37887529)
1. Epithelial Membrane Protein-3 and Chitinase-3-like Protein-1 as New Prognostic Predictors of Glioma, a Two-Gene Study.
Shen K; Zhu J; Zhou S; Jin X; Zhai W; Sun L; Wu J; Yu Z
Curr Oncol; 2023 Sep; 30(10):8686-8702. PubMed ID: 37887529
[TBL] [Abstract][Full Text] [Related]
2. EMP3 as a prognostic biomarker correlates with EMT in GBM.
Li L; Xia S; Zhao Z; Deng L; Wang H; Yang D; Hu Y; Ji J; Huang D; Xin T
BMC Cancer; 2024 Jan; 24(1):89. PubMed ID: 38229014
[TBL] [Abstract][Full Text] [Related]
3. The Multifunctional Role of EMP3 in the Regulation of Membrane Receptors Associated with IDH-Wild-Type Glioblastoma.
Martija AA; Pusch S
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067658
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a nomogram with EMP3 for predicting clinical outcomes in patients with glioma: A bi-center study.
Zhang A; Xu H; Zhang Z; Liu Y; Han X; Yuan L; Ni Y; Gao S; Xu Y; Chen S; Jiang J; Chen Y; Zhang X; Lou M; Zhang J
CNS Neurosci Ther; 2021 Oct; 27(10):1238-1250. PubMed ID: 34268874
[TBL] [Abstract][Full Text] [Related]
5. PPIC, EMP3 and CHI3L1 Are Novel Prognostic Markers for High Grade Glioma.
Gao YF; Zhu T; Mao CX; Liu ZX; Wang ZB; Mao XY; Li L; Yin JY; Zhou HH; Liu ZQ
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801851
[TBL] [Abstract][Full Text] [Related]
6. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
7. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.
Jun F; Hong J; Liu Q; Guo Y; Liao Y; Huang J; Wen S; Shen L
Oncotarget; 2017 Feb; 8(9):14343-14358. PubMed ID: 27527869
[TBL] [Abstract][Full Text] [Related]
8. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
Liu J; Xu K; Ma L; Wang Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
[TBL] [Abstract][Full Text] [Related]
9. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M
Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of age related genes in patients with lower grade glioma.
Wang H; Wang X; Xu L; Zhang J; Cao H
J Cancer; 2020; 11(13):3986-3999. PubMed ID: 32328202
[No Abstract] [Full Text] [Related]
11. Whole-Genome Expression Microarray Combined with Machine Learning to Identify Prognostic Biomarkers for High-Grade Glioma.
Shu C; Wang Q; Yan X; Wang J
J Mol Neurosci; 2018 Apr; 64(4):491-500. PubMed ID: 29502292
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation of the EMP3 gene in a series of 229 human gliomas.
Mellai M; Piazzi A; Caldera V; Annovazzi L; Monzeglio O; Senetta R; Cassoni P; Schiffer D
Biomed Res Int; 2013; 2013():756302. PubMed ID: 24083241
[TBL] [Abstract][Full Text] [Related]
13. High EMP3 expression might independently predict poor overall survival in glioblastoma and its expression is related to DNA methylation.
Yue H; Xu Q; Xie S
Medicine (Baltimore); 2018 Jan; 97(1):e9538. PubMed ID: 29505529
[TBL] [Abstract][Full Text] [Related]
14. CHI3L1 predicted in malignant entities is associated with glioblastoma immune microenvironment.
Li F; Qi B; Yang L; Wang B; Gao L; Zhao M; Luo L
Clin Immunol; 2022 Dec; 245():109158. PubMed ID: 36244672
[TBL] [Abstract][Full Text] [Related]
15. Identification of candidate biomarker
Lv Q; Xiao W; Xiong Z; Shi J; Miao D; Meng X; Yuan H; Yang H; Zhang X
Front Biosci (Landmark Ed); 2021 Nov; 26(11):1176-1190. PubMed ID: 34856762
[No Abstract] [Full Text] [Related]
16. Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas.
Zeng WJ; Yang YL; Liu ZZ; Wen ZP; Chen YH; Hu XL; Cheng Q; Xiao J; Zhao J; Chen XP
Cell Physiol Biochem; 2018; 47(1):428-439. PubMed ID: 29794476
[TBL] [Abstract][Full Text] [Related]
17. LOH 19q indicates shorter disease progression-free interval in low-grade oligodendrogliomas with EMP3 methylation.
Pasini A; Iorio P; Bianchi E; Cerasoli S; Cremonini AM; Faedi M; Guarnieri C; Guiducci G; Riccioni L; Molinari C; Rengucci C; Calistri D; Giordano E
Oncol Rep; 2012 Dec; 28(6):2271-7. PubMed ID: 22992787
[TBL] [Abstract][Full Text] [Related]
18. TIMP1/CHI3L1 facilitates glioma progression and immunosuppression via NF-κB activation.
Xu J; Wei C; Wang C; Li F; Wang Z; Xiong J; Zhou Y; Li S; Liu X; Yang G; Han L; Zhang J; Zhang S
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167041. PubMed ID: 38290591
[TBL] [Abstract][Full Text] [Related]
19. CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines.
Li YF; Tsai WC; Chou CH; Huang LC; Huang SM; Hueng DY; Tsai CK
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375517
[TBL] [Abstract][Full Text] [Related]
20. MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.
Sun JZ; Zhang JH; Li JB; Yuan F; Tong LQ; Wang XY; Chen LL; Fan XG; Zhang YM; Ren X; Zhang C; Yu SP; Yang XJ
Dis Markers; 2021; 2021():6680883. PubMed ID: 34211612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
